NVS Description — Novartis AG Basel

Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two global business units, Novartis Oncology and Novartis Pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals.

Company Name: 
Novartis AG Basel
Drugs & Pharmaceuticals
Number of ETFs Holding NVS: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   NVS Weight   NVS Amount 
 FVD   0.55%   $68,953,174         
 PPH   5.30%   $30,395,914         
 PID   2.52%   $25,175,386         
 KOMP   0.08%   $1,323,203         
 FTHI   0.26%   $284,214         
Quotes delayed 20 minutes

Email EnvelopeFree NVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.14 out of 4)
35th percentile
(ranked lower than approx. 65% of all stocks covered)

Analysts Forecast:
NVS Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding NVS | Novartis AG Basel | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.